196 related articles for article (PubMed ID: 21910867)
1. Reducing selection bias in case-control studies from rare disease registries.
Cole JA; Taylor JS; Hangartner TN; Weinreb NJ; Mistry PK; Khan A
Orphanet J Rare Dis; 2011 Sep; 6():61. PubMed ID: 21910867
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
Khan A; Hangartner T; Weinreb NJ; Taylor JS; Mistry PK
J Bone Miner Res; 2012 Aug; 27(8):1839-48. PubMed ID: 22692814
[TBL] [Abstract][Full Text] [Related]
3. Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis.
Mistry PK; Deegan P; Vellodi A; Cole JA; Yeh M; Weinreb NJ
Br J Haematol; 2009 Nov; 147(4):561-70. PubMed ID: 19732054
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Baseline characteristics of 32 patients with Gaucher disease who were treated with imiglucerase: South African data from the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
Sevittz H; Laher F; Varughese ST; Nel M; McMaster A; Jacobson BF
S Afr Med J; 2022 Feb; 112(1):13518. PubMed ID: 35140000
[TBL] [Abstract][Full Text] [Related]
6. Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment.
Weinreb NJ; Camelo JS; Charrow J; McClain MR; Mistry P; Belmatoug N;
Mol Genet Metab; 2021 Feb; 132(2):100-111. PubMed ID: 33485799
[TBL] [Abstract][Full Text] [Related]
7. Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model.
Bellgard MI; Napier KR; Bittles AH; Szer J; Fletcher S; Zeps N; Hunter AA; Goldblatt J
Blood Cells Mol Dis; 2018 Feb; 68():232-238. PubMed ID: 28190666
[TBL] [Abstract][Full Text] [Related]
8. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.
Rosenbloom B; Balwani M; Bronstein JM; Kolodny E; Sathe S; Gwosdow AR; Taylor JS; Cole JA; Zimran A; Weinreb NJ
Blood Cells Mol Dis; 2011 Jan; 46(1):95-102. PubMed ID: 21067946
[TBL] [Abstract][Full Text] [Related]
9. Life expectancy in Gaucher disease type 1.
Weinreb NJ; Deegan P; Kacena KA; Mistry P; Pastores GM; Velentgas P; vom Dahl S
Am J Hematol; 2008 Dec; 83(12):896-900. PubMed ID: 18980271
[TBL] [Abstract][Full Text] [Related]
10. Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry.
Tylki-Szymańska A; Vellodi A; El-Beshlawy A; Cole JA; Kolodny E
J Inherit Metab Dis; 2010 Aug; 33(4):339-46. PubMed ID: 20084461
[TBL] [Abstract][Full Text] [Related]
11. Gaucher disease and cancer incidence: a study from the Gaucher Registry.
Rosenbloom BE; Weinreb NJ; Zimran A; Kacena KA; Charrow J; Ward E
Blood; 2005 Jun; 105(12):4569-72. PubMed ID: 15718419
[TBL] [Abstract][Full Text] [Related]
12. Report of the Spanish Gaucher's disease registry: clinical and genetic characteristics.
Giraldo P; Pocoví M; Pérez-Calvo J; Rubio-Félix D; Giralt M
Haematologica; 2000 Aug; 85(8):792-9. PubMed ID: 10942924
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.
Grabowski GA; Kacena K; Cole JA; Hollak CE; Zhang L; Yee J; Mistry PK; Zimran A; Charrow J; vom Dahl S
Genet Med; 2009 Feb; 11(2):92-100. PubMed ID: 19265748
[TBL] [Abstract][Full Text] [Related]
14. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
Mezei G; Chang ET; Mowat FS; Moolgavkar SH
Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
[TBL] [Abstract][Full Text] [Related]
15. Osseous manifestations of adult Gaucher disease in the era of enzyme replacement therapy.
Deegan PB; Pavlova E; Tindall J; Stein PE; Bearcroft P; Mehta A; Hughes D; Wraith JE; Cox TM
Medicine (Baltimore); 2011 Jan; 90(1):52-60. PubMed ID: 21200186
[TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis in Gaucher disease in the era of multiple therapies: Biomarker set for risk stratification from a tertiary referral center.
Basiri M; Ghaffari ME; Ruan J; Murugesan V; Kleytman N; Belinsky G; Akhavan A; Lischuk A; Guo L; Klinger K; Mistry PK
Elife; 2023 May; 12():. PubMed ID: 37249220
[TBL] [Abstract][Full Text] [Related]
17. [Organization of Gaucher disease management in France].
Stirnemann J; de Villemeur TB; Belmatoug N
Rev Med Interne; 2007 Oct; 28 Suppl 2():S198-201. PubMed ID: 18228688
[TBL] [Abstract][Full Text] [Related]
18. Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry.
Mistry PK; Batista JL; Andersson HC; Balwani M; Burrow TA; Charrow J; Kaplan P; Khan A; Kishnani PS; Kolodny EH; Rosenbloom B; Scott CR; Weinreb N
Am J Hematol; 2017 Sep; 92(9):929-939. PubMed ID: 28569047
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic heterogeneity of N370S homozygotes with type I Gaucher disease: an analysis of 798 patients from the ICGG Gaucher Registry.
Fairley C; Zimran A; Phillips M; Cizmarik M; Yee J; Weinreb N; Packman S
J Inherit Metab Dis; 2008 Dec; 31(6):738-44. PubMed ID: 18979180
[TBL] [Abstract][Full Text] [Related]
20. The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.
Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ; Zimran A
Arch Intern Med; 2000 Oct; 160(18):2835-43. PubMed ID: 11025794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
